Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.
about
Th17 cells in autoimmune and infectious diseasesReview: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyondSecukinumab for ankylosing spondylitis and psoriatic arthritisPolymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy.Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.The Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesNon-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis.Ankylosing spondylitis: from cells to genesMechanistic rationales for targeting interleukin-17A in spondyloarthritis.Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts.Assay of Peripheral Regulatory Vδ1 T Cells in Ankylosing Spondylitis and its Significance.Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis.The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis.TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.Role of Stem Cells in Pathophysiology and Therapy of Spondyloarthropathies-New Therapeutic Possibilities?Spreading spondyloarthritis: are ILCs cytokine shuttles from base camp gut?The Postoperative Immunosuppressive Phenotypes of Peripheral T Helper Cells Are Associated with Poor Prognosis of Breast Cancer Patients.IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities.Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells.MicroRNA-124 involves in ankylosing spondylitis by targeting ANTXR2.Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis
P2860
Q21284677-6BDD7A78-7BC7-46F1-A877-59635D6B9F28Q26991709-BC4A4C61-233C-4A50-B88D-5788DB9D201DQ28071474-D2E7F57F-4F6D-4E6D-B4DC-C45635A8ACACQ33406925-7E1662E3-DEAB-449F-9DB9-CC8B043A75ACQ34032964-C891AE18-F9AE-4F27-9105-23AED676A6CAQ36249305-38FAB3BE-F455-40B0-BA22-54EDEB757DE9Q36913820-C9E23569-7200-4AD8-BED4-F9F2753278F8Q37045417-B442AD4A-734A-4A98-9DF9-C2A5D6DAB8D4Q37077734-6152E81A-86CF-405F-A183-B8FB76A79555Q37686009-6FEA6469-FFDE-4AC2-898A-C58E7CD1A5E7Q38154628-FD277C2D-6A52-49D2-9C92-61D4E93EF72FQ38816459-3144B7AD-8FE9-4001-B0AA-E4AAF1B36764Q41088480-1046E9F5-FF6F-4571-A6B2-EA776CAF3A3AQ46154278-40FC35C3-A128-429B-8467-5EAB299C126BQ47357132-D95F5185-CC80-4EE0-85CF-4496846C8DD1Q48119880-DB6F75D7-B7EA-4135-B08F-30C062B27C28Q48337725-D80BDBF9-32CF-4A47-A74F-1784FDAC779FQ49124951-029BE086-AC4C-41AE-A8B7-D3C11E5FCEF0Q50222370-BB998A0F-23FB-48EE-A2AC-99EF17B79B52Q50776951-76B14B05-524D-45D0-BEBE-94B3C1B98B40Q51762547-5354F22E-134F-40AC-B61B-720D5712DB94Q53023578-A626DDAB-9253-43AD-BFA5-5A78AD3C0FBEQ53340748-F2C01BD4-38C7-46EE-A9C2-8B13B4183A73Q55339808-4ACE860C-B8FD-45BE-8020-A05BC1662B68Q55386131-FA90CDE2-808F-4250-8B7A-B75E413C1CD7Q58747224-DF8D2F9C-A3C8-4FAE-89F2-E9A3D9A044F5
P2860
Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Levels of circulating Th17 cel ...... esponse to anti-TNF-α therapy.
@en
Levels of circulating Th17 cel ...... esponse to anti-TNF-α therapy.
@nl
type
label
Levels of circulating Th17 cel ...... esponse to anti-TNF-α therapy.
@en
Levels of circulating Th17 cel ...... esponse to anti-TNF-α therapy.
@nl
prefLabel
Levels of circulating Th17 cel ...... esponse to anti-TNF-α therapy.
@en
Levels of circulating Th17 cel ...... esponse to anti-TNF-α therapy.
@nl
P2093
P2860
P1476
Levels of circulating Th17 cel ...... esponse to anti-TNF-α therapy.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10875-012-9774-0
P577
2012-08-29T00:00:00Z